Skip to Main Content

Paper Details

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.
Cell
193
2021
CD161, CD161 receptor, IDH, IDH mutant glioma, Inhibitory, KLRB1, NK cell receptors, NK gene, NK gene KLRB1, T cell populations, T cells, cancer, cancers, clonally expanded tumor-infiltrating T cells, gene, glioma, glioma cells, glioma-infiltrating T cells, gliomas, human, isocitrate, isocitrate dehydrogenase, natural killer (NK) cell genes, patients, single, tumor, tumor-infiltrating T cells
Author NameAffiliation
Orr AshenbergBroad Institute of MIT and Harvard, Broad Institute of Harvard and MIT
Itay TiroshWeizmann Institute of Science
Elizabeth M PerezBroad Institute of MIT and Harvard, Broad Institute of Harvard and MIT, USA Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School
Kathrin SchumannUniversity of California, USA Institute for Medical Microbiology, Technische Universitat Munchen (TUM)
Orit Rozenblatt-RosenBroad Institute of MIT and Harvard, Broad Institute of Harvard and MIT
Priscilla K BrastianosMassachusetts General Hospital Cancer Center, Harvard Medical School
Xiaole Shirley LiuDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Matthew P FroschDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital
Matthew P FroschDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital
David N LouisDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital
Keith L LigonBrigham and Women's Hospital
Alexander MarsonUniversity of California, USA Gladstone Institutes san francisco
Aviv RegevBroad Institute of MIT and Harvard, Broad Institute of Harvard and MIT, USA Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research
Aviv RegevBroad Institute of MIT and Harvard, Broad Institute of Harvard and MIT, USA Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research
Mario L Suv??Broad Institute of MIT and Harvard, Broad Institute of Harvard and MIT, USA Department of Pathology and Center for Cancer Research, Massachusetts General Hospital
Mario L Suv??Broad Institute of MIT and Harvard, Broad Institute of Harvard and MIT, USA Department of Pathology and Center for Cancer Research, Massachusetts General Hospital
  • 1 - 16

Datasets